HealthMore in Health→
Moderna Pays $950M to Settle COVID Vaccine Patent Fight
Key Takeaways
- Moderna pays $950M upfront to settle LNP patent dispute
- Patents cover lipid nanoparticle tech critical to mRNA vaccine delivery
- Settlement removes major legal overhang as Moderna pursues new therapies
DE
DT Editorial Team··4 min read·via endpoints.news